Compare Bio Protocol (BIO) vs Parcl (PRCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Parcl — how do they compare? Bio Protocol trades at Rp438.42 (market cap Rp990,24M, Rp174,03M 24h volume), while Parcl trades at Rp90.26 (market cap Rp37,18M, Rp6,3M 24h volume). The key difference: Bio Protocol is far larger — about 26.6× Parcl's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 412,3M / 1B PRCL (42%) for Parcl. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Parcl for 16 Days on average.
| BIO | PRCL | |
|---|---|---|
Market Cap | Rp990,24M | Rp37,18M |
Volume (24h) | Rp174,03M | Rp6,3M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 412,3M / 1B PRCL (42%) |
Typical Hold Time | 18 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Parcl is trading at Rp91.564, exhibiting a bearish technical stance with moving averages signaling strong selling pressure, though oscillators are neutral. The current price sits just below the pivot point of Rp94, with immediate support at Rp88. With a market cap of Rp37.59 million and a circulation rate of 42%, the token's on-chain activity remains limited. No major protocol upgrades or ecosystem developments were reported recently.
Overall outlook is cautious due to prevailing bearish momentum and low liquidity. Key opportunities include potential rebounds from oversold RSI levels, while major risks involve high volatility, thin trading volumes, and the token's low market cap making it susceptible to sharp price swings. Investors should monitor for any breakout above Rp94 resistance for a shift in short-term momentum.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Parcl
The Parcl Ecosystem—comprising Parcl, Parcl Labs, and Parcl Limited—develops and governs the Parcl Protocol, a decentralized platform enabling users to take long or short positions on real-world real estate prices. By leveraging world-class real estate data from Parcl Labs, Parcl aims to create a liquid market around the largest asset class globally. The PRCL token powers the ecosystem, offering governance rights, access to Parcl Labs’ data and analytics, and network incentives.
Read more on PRCL →
